Billionaires Holding OGXI

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 21.3M
    Shares Outstanding

  • 25.07M
    Market Cap

News & Insights

ABOUT

OGXI

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes therapies that address treatment resistance in cancer patients. Its lead drug candidate, Custirsen is in Phase III clinical development for the treatment in men with metastatic castrate-resistant prostate ca...

The Apple Earnings Report - What You Need To Know

NEWS

Facebook reports another mega quarter, crushing revenue

READ MORE